AR109248A1 - Procedimiento para la preparación de 4-fenilbutirato y sus usos - Google Patents
Procedimiento para la preparación de 4-fenilbutirato y sus usosInfo
- Publication number
- AR109248A1 AR109248A1 ARP170101424A ARP170101424A AR109248A1 AR 109248 A1 AR109248 A1 AR 109248A1 AR P170101424 A ARP170101424 A AR P170101424A AR P170101424 A ARP170101424 A AR P170101424A AR 109248 A1 AR109248 A1 AR 109248A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenyl
- butyric acid
- procedure
- preparation
- triphenylbutyrate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- AUGQXKXDRJHZMR-UHFFFAOYSA-N 2,3-dihydroxypropyl 4,4,4-triphenylbutanoate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(CCC(=O)OCC(O)CO)C1=CC=CC=C1 AUGQXKXDRJHZMR-UHFFFAOYSA-N 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 abstract 2
- LDZLXQFDGRCELX-UHFFFAOYSA-N 4-phenylbutan-1-ol Chemical compound OCCCCC1=CC=CC=C1 LDZLXQFDGRCELX-UHFFFAOYSA-N 0.000 abstract 1
- 208000028547 Inborn Urea Cycle disease Diseases 0.000 abstract 1
- 239000005708 Sodium hypochlorite Substances 0.000 abstract 1
- YLFIGGHWWPSIEG-UHFFFAOYSA-N aminoxyl Chemical compound [O]N YLFIGGHWWPSIEG-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 abstract 1
- 229960002218 sodium chlorite Drugs 0.000 abstract 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 abstract 1
- 235000010265 sodium sulphite Nutrition 0.000 abstract 1
- 208000030954 urea cycle disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/616—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
- C07C51/29—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation with halogen-containing compounds which may be formed in situ
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/58—Preparation of carboxylic acid halides
- C07C51/60—Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un procedimiento para preparar ácido 4-fenil-1-butírico, que comprende: hacer reaccionar 4-fenil-1-butanol con clorito sódico, un catalizador del radical nitroxilo e hipoclorito sódico en un disolvente orgánico y un amortiguador de fosfato; y paralizar la reacción con sulfito sódico para producir 4-fenil-1-butírico. También ácido 4-fenil-1-butírico preparado mediante tal procedimiento. Preparación de trifenilbutirato de glicerilo y su uso en el tratamiento de un trastorno del ciclo de la urea. Reivindicación 25: Un procedimiento para preparar trifenilbutirato de glicerol, caracterizado porque comprende: convertir ácido 4-fenil-1-butírico de la reivindicación 21, en cloruro de 4-fenil-1-butirilo; y hacer reaccionar el cloruro de 4-fenil-1-butirilo con glicerol en un disolvente orgánico en presencia de una base adecuada.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/164,126 US9914692B2 (en) | 2016-05-25 | 2016-05-25 | Procedure for the preparation of 4-phenyl butyrate and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109248A1 true AR109248A1 (es) | 2018-11-14 |
Family
ID=60412929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101424A AR109248A1 (es) | 2016-05-25 | 2017-05-24 | Procedimiento para la preparación de 4-fenilbutirato y sus usos |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US9914692B2 (es) |
| AR (1) | AR109248A1 (es) |
| TW (1) | TW201741278A (es) |
| WO (1) | WO2017205515A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102019000B1 (ko) | 2011-09-30 | 2019-09-05 | 호라이즌 쎄라퓨틱스, 엘엘씨. | 질소 스캐빈징 약물들의 치료학적 모니터링 방법들 |
| US9914692B2 (en) | 2016-05-25 | 2018-03-13 | Horizon Therapeutics, Llc | Procedure for the preparation of 4-phenyl butyrate and uses thereof |
| US10668040B2 (en) | 2017-09-11 | 2020-06-02 | Horizon Therapeutics, Llc | Treatment of urea cycle disorders in neonates and infants |
| CN108530290A (zh) * | 2018-06-04 | 2018-09-14 | 福州华博立乐新材料科技有限公司 | 一种4-苯基-1-丁酸的合成方法 |
| CN113845420B (zh) * | 2021-10-22 | 2024-04-16 | 安徽沃泰生物医药有限公司 | 苯丁酸甘油酯的合成工艺 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3686238A (en) | 1970-01-19 | 1972-08-22 | Syntex Corp | Glycerol esterified with 2-naphthyl-acetic acids and fatty acids |
| US4284647A (en) | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| US4457942A (en) | 1982-08-20 | 1984-07-03 | Brusilow Saul W | Process for waste nitrogen removal |
| US5635532A (en) | 1991-10-21 | 1997-06-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
| US5879657A (en) | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| ATE201013T1 (de) | 1995-02-07 | 2001-05-15 | Brusilow Entpr Llc | Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen |
| US6219567B1 (en) | 1999-06-21 | 2001-04-17 | Cardiox Corporation | Monitoring of total ammoniacal concentration in blood |
| IT1317073B1 (it) | 2000-12-12 | 2003-05-26 | Mini Ricerca Scient Tecnolog | Esteri dell'acido fenilbutirrico, procedimenti per la loro produzionee loro impiego terapeutico. |
| US6372938B1 (en) * | 2001-05-21 | 2002-04-16 | Stanislaw R. Burzynski | Synthesis of 4-phenylbutyric acid |
| US20040229948A1 (en) | 2002-04-12 | 2004-11-18 | Summar Marshall L. | Method for preventing hepatic encephalopathic episodes |
| US20030195255A1 (en) | 2002-04-12 | 2003-10-16 | Summar Marshall L. | Method for treating hepatic encephalopathies |
| US6825384B1 (en) | 2004-01-29 | 2004-11-30 | The Nutrasweet Company | Bromine free TEMPO based catalyst system for oxidation of primary and secondary alcohols using NaOCl as an oxidant |
| US20050273359A1 (en) | 2004-06-03 | 2005-12-08 | Young David E | System and method of evaluating preoperative medical care and determining recommended tests based on patient health history and medical condition and nature of surgical procedure |
| CN1778963A (zh) | 2004-11-23 | 2006-05-31 | 苏州艾杰生物科技有限公司 | 血氨含量测定方法及血氨诊断试剂盒 |
| PL1824563T3 (pl) | 2004-11-26 | 2010-07-30 | Ucl Business Plc | Kompozycje zawierające ornitynę i fenylooctan lub fenylomaślan do leczenia encefalopatii wątrobowej |
| US20060135612A1 (en) | 2004-12-17 | 2006-06-22 | U.S. Department Of Veterans Affairs | Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent |
| US20070004805A1 (en) | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| US20100016207A1 (en) | 2005-11-10 | 2010-01-21 | Wurtman Richard J | Methods and Compositions for Raising Levels and Release of Gamma Aminobutyric Acid |
| CN101096363B (zh) * | 2006-06-27 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途 |
| US8094521B2 (en) | 2007-02-28 | 2012-01-10 | Nightingale Products LLC | Caregiver personal alert device |
| CN101959429B (zh) | 2008-01-08 | 2014-09-10 | 阿克塞利亚制药公司 | 抗微生物肽系统的激动剂 |
| EP3133396B1 (en) | 2008-04-29 | 2018-09-05 | Horizon Therapeutics, LLC | Methods of treatment using ammonia-scavenging drugs |
| WO2009145323A1 (ja) * | 2008-05-30 | 2009-12-03 | 日産化学工業株式会社 | 多環式化合物を用いるアルコールの酸化方法 |
| DK3133396T3 (en) | 2008-08-29 | 2018-12-03 | Horizon Therapeutics Llc | METHODS OF TREATMENT WHEN USING AMMONIA-CLEANING MEDICINES |
| WO2010025303A1 (en) | 2008-08-29 | 2010-03-04 | Hyperion Therapeutics | Dosing and monitoring patients on nitrogen-scavenging drugs |
| PT2456304E (pt) | 2009-07-24 | 2015-10-12 | Baylor College Medicine | Métodos de modulação de ácidos de cadeia ramificada e utilização dos mesmos |
| US8871981B2 (en) | 2010-07-16 | 2014-10-28 | Tohoku University | Method for oxidizing alcohols |
| US20130224277A1 (en) | 2010-08-31 | 2013-08-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation |
| KR102019000B1 (ko) | 2011-09-30 | 2019-09-05 | 호라이즌 쎄라퓨틱스, 엘엘씨. | 질소 스캐빈징 약물들의 치료학적 모니터링 방법들 |
| EP2607366A1 (en) | 2011-12-21 | 2013-06-26 | Lunamed AG | Glycerol phenyl butyrate esters |
| AU2012377389A1 (en) | 2012-04-20 | 2014-10-30 | Horizon Therapeutics Llc | Methods of therapeutic monitoring of phenylacetic acid prodrugs |
| EP3335735A1 (en) * | 2012-11-21 | 2018-06-20 | Horizon Therapeutics, LLC | Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy |
| CN103304402B (zh) | 2013-05-24 | 2015-04-22 | 苏州诚和医药化学有限公司 | 一种制备4-苯-1-丁酸的方法 |
| US20150094278A1 (en) | 2013-09-30 | 2015-04-02 | Hyperion Therapeutics, Inc. | Methods of diagnosing, grading, monitoring, and treating hepatic encephalopathy |
| PL2986325T3 (pl) | 2013-10-14 | 2020-03-31 | Immedica Pharma Ab | Sposoby leczenia zaburzenia cyklu mocznikowego |
| IN2013MU03442A (es) | 2013-10-30 | 2015-07-17 | Lupin Ltd | |
| US20170087113A1 (en) | 2014-06-04 | 2017-03-30 | Horizon Therapeutics, Llc | Methods for treating urea cycle disorders to prevent hyperammonemic crises by controlling blood ammonia levels |
| WO2017147193A1 (en) | 2016-02-22 | 2017-08-31 | Horizon Therapeutics, Llc | Treatment of urea cycle disorders in neonates and infants |
| US9914692B2 (en) | 2016-05-25 | 2018-03-13 | Horizon Therapeutics, Llc | Procedure for the preparation of 4-phenyl butyrate and uses thereof |
| US20190076383A1 (en) | 2017-09-08 | 2019-03-14 | Horizon Therapeutics, Llc | Methods for treating urea cycle disorders |
| US10668040B2 (en) | 2017-09-11 | 2020-06-02 | Horizon Therapeutics, Llc | Treatment of urea cycle disorders in neonates and infants |
-
2016
- 2016-05-25 US US15/164,126 patent/US9914692B2/en active Active
-
2017
- 2017-05-24 WO PCT/US2017/034286 patent/WO2017205515A1/en not_active Ceased
- 2017-05-24 AR ARP170101424A patent/AR109248A1/es unknown
- 2017-05-25 TW TW106117412A patent/TW201741278A/zh unknown
- 2017-09-06 US US15/696,448 patent/US10329236B2/en active Active
-
2019
- 2019-05-07 US US16/405,523 patent/US11014870B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20170362160A1 (en) | 2017-12-21 |
| US20200002266A1 (en) | 2020-01-02 |
| TW201741278A (zh) | 2017-12-01 |
| US10329236B2 (en) | 2019-06-25 |
| US11014870B2 (en) | 2021-05-25 |
| WO2017205515A1 (en) | 2017-11-30 |
| US20170342018A1 (en) | 2017-11-30 |
| US9914692B2 (en) | 2018-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR109248A1 (es) | Procedimiento para la preparación de 4-fenilbutirato y sus usos | |
| CL2020002805A1 (es) | Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526) | |
| AR103930A1 (es) | Proceso para preparar mesotriona | |
| CO2018010877A2 (es) | Ácido acrílico y métodos de producción del mismo | |
| UY37428A (es) | Modulador del regulador de conductancia de transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador | |
| EA201790727A1 (ru) | Способ получения диола | |
| MX2015017870A (es) | Procedimiento para producir 4-propargilado amino-benzoxazinonas. | |
| AR097882A1 (es) | Método para procesar la biomasa que contiene celulosa | |
| AR098798A1 (es) | Procedimiento para la diazotización de 2,5-dicloroanilinas | |
| MX2018001966A (es) | Deshidrohalogenacion de hidroclorofluorocarburos. | |
| EA201990415A1 (ru) | Плавучий модуль для модульных платформ солнечных панелей | |
| UY35124A (es) | Método para la producción de ácido peracético en equilibrio, y ácido peracético en equilibrio que se puede obtener con dicho método | |
| CO6590210A1 (es) | Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina | |
| AR107494A1 (es) | Proceso para la preparación de osimertinib (azd9291) o una sal del mismo, y azd9291 anilina o una sal de la misma | |
| MX2017000023A (es) | Proceso para preparar fenilalcanos sustituidos. | |
| AR097596A1 (es) | Proceso para preparar celulosa | |
| CL2011002069A1 (es) | Metodo para modificar carbohidrato que comprende formar una mezcla del carbohidrato con un solvente y la reaccion del carbohidrato con radicales hidroxilo que son generados por fotolisis de peroxido en solucion acuoso, con una relacion de luz uv a peroxido de 20-500 watts/g. | |
| CL2016002864A1 (es) | Método para modificar madera | |
| BR112017022395A2 (pt) | método para preparação de um agente de direcionamento de estrutura, e, composição | |
| CO6511211A2 (es) | Composiciones estable de sns 595 y métodos de preparación | |
| CL2018000202A1 (es) | Método e instalación para una síntesis química | |
| AR099705A1 (es) | Sistema y método para producir hidrógeno | |
| AR099070A1 (es) | Ácido (s)- 3-metil-abscísico y ésteres del mismo | |
| AR095548A1 (es) | Preparación de ácido 4-amino-2,4-dioxobutanoico | |
| AR098023A1 (es) | Un proceso para preparar isoxaflutol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |